Острые лейкозы: литература
Hoelzer D, Gokbuget N. New approaches to acute lymphoblastic leukemia in adults: Where do we go? Semin Oncol 2000; 27:540.
Kottaridis PD, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001; 98:1752.
Larson RA, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group В study 8811. Blood 1995; 85:2025.
Larson RA, et al. Treatment of biologically determined subsets of acute lymphoblastic leukemia in adults: Cancer and Leukemia Group В studies. In: Buchner T, Hiddeman W, Wormann B, et al., eds. Acute Leukemias. VI: Prognostic Factors and Treatment Strategies. Springer- Verlag, Berlin, 1997:677.
Mayer Robert J, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331:896.
Sievers SL, et al. Efficacy and safety ofgemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol 2001; 19:3244.
Silverman LB, et al. Improved outcome for children with acute lymphobastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001; 97:1211.
Tallman MS, et al. Acute promyelocytic leukemia: evolving therapeutic strategies [review]. Blood 2002; 99:759.
Tallman MS, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000; 95:90.
Vardiman JW, et al. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100:2292.
Wheatley K. Current controversies: which patients with acute myeloid leukemia should receive a bone marrow transplantation? A statistician's view. Br J Haematol 2002; 118:351.
Смотрите также:
